Аннотация: В представленной статье обсуждаются возможности магнитно-резонансной томографии с внутривенным контрастным усилением и определением «индекса накопления» в диагностике рака предстательной железы. Проведен сравнительный анализ индексов накопления контрастного вещества в опухолевой ткани и доброкачественных изменениях предстательной железы. Доказывается эффективность предложенной методики в постановке диагноза и локализации патологического процесса. Список литературы 1. Franiel Т., Stephan C., Erbersdobler A., Dietz E. Maxeiner A. et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology. 2011; 259:162-172. 2. Kitajima K., Kaji Y, Fukabori Y, Yoshida K., Suganuma N. et al. Prostate cancer detection with 3T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J. Magn. Reson. Imaging. 2010; 31: 625-631. 3. Futterer J.J., Heijmink S.W., Scheenen T.W., Veltman J., Huisman H.J. et al. Prostate cancer localization with dynamic contrastenhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006; 241:449-458. 4. Tanimoto A., Nakashima J., Kohno H., Shinmoto H., Kuribayashi S. Prostate cancer screening: the clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J. Magn. Reson. Imaging. 2007; 25:146-152. 5. EL-Gabry E.A., Halpern E.J., Strup S.E., et al. Imaging prostate cancer; current and future applications. Oncology Huntingt. 2001; 15: 325-336. 6. Engelbrecht MR, Huisman HJ, Laheij R.J. MR imaging Radiology 2003; 229: 248-254. 7. Hara N., Okuizumi M. Koike H., Kawaguchi M., Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) is a useful modality for the precise detection and staging of early prostate cancer. Eur. Radiol. 2012; 22: 746-757. 8. Nicholson B., Schaefer G., Theodorescu D. Angiogenesis in prostate cancer: biology and therapeutic opportunities. Cancer Metastasis Rev. 2001; 20: 297-319. 9. Beyersdorff D., Taupitz M., Winkelmann B. et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology. 2002; 224: 701-706. 10. Pasquier D., Hugentobler A., Masson P Which imaging methods should be used before salvage radiotherapy after prostatectomy for prostate cancer? Eur. Radiol. 2012; 22: 746-757. 11. Cirillo S., Petracchini M., Scotti L. et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur. Radiol. 2009; 19: 761-769 12. ESUR prostate MR guidelines 2012 Jelle O. Barentsz & Jonathan Richenberg & Richard Clements & Peter Choyke & Sadhna Verma & Geert Villeirs & Olivier Rouviere & Vibeke Logager & Jurgen J. F^tere^ Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast enhanced MR imaging. Radiology. 2003; 229: 248-254